Cargando…
Quantifying geographical accessibility to cancer clinical trials in different income landscapes
BACKGROUND: Clinical trials are increasingly perceived as a therapeutic opportunity for cancer patients. Favoring their concentration in few high-expertise academic centers maximizes quality of data collection but poses an issue of access equality. Analytical tools to quantify trial accessibility ar...
Autores principales: | Tini, G., Trapani, D., Duso, B.A., Beria, P., Curigliano, G., Pelicci, P.G., Mazzarella, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271515/ https://www.ncbi.nlm.nih.gov/pubmed/35738201 http://dx.doi.org/10.1016/j.esmoop.2022.100515 |
Ejemplares similares
-
Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness
por: Tini, Giulia, et al.
Publicado: (2020) -
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
por: Mazzarella, Luca, et al.
Publicado: (2020) -
Quantifying geographic accessibility to improve efficiency of entomological monitoring
por: Longbottom, Joshua, et al.
Publicado: (2020) -
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development
por: Tarantino, Paolo, et al.
Publicado: (2019) -
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
por: de Guillebon, E., et al.
Publicado: (2021)